1. United States of America Stocks

  2. •

    Consumer Defensive

  3. •

    Packaged Foods
Merion, Inc.

Merion, Inc.

EWLU
Merion, Inc.US flagOther OTC
0.00
USD
- -
- -
6,229.00Market Cap
2012 Y
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
TTM
Revenue per Share
0.01
0.08
0.14
0.01
0.02
0.02
0.01
0.03
0.01
0.02
0.01
Basic EPS, GAAP
-0.03
0.04
-0.02
-0.07
-0.02
-0.02
-0.05
-0.01
-0.03
-0.02
-0.02
Free Cash Flow per Basic Share
0.02
0.08
-0.08
-0.04
-0.01
-0.01
-0.03
-0.02
-0.02
- -
-0.01
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
-0.26
-0.22
-0.28
-0.34
-0.38
-0.38
-0.39
-0.39
-0.42
-0.42
-0.43
Tangible Book Value per Share
-0.2
-0.16
-0.15
-0.27
-0.3
-0.15
-0.11
-0.09
- -
-0.02
-0.03
Basic Weighted Avg Shares
56
56
49
50
48
49
57
59
59
62
62
Sales/Revenue/Turnover
- -
5
7
- -
1
1
- -
2
- -
1
1
Operating Margin (%)
-316.9
48.1
41.07
-841.22
-74.31
-93.95
-625.38
-50.52
-416.74
-73.49
-208.79
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
-1
2
-1
-3
-1
-1
-3
-1
-2
-1
-1
Effective Tax Rate (%)
- -
0.58
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
-316.9
47.7
-15.7
-920.9
-80.92
-136.23
-830.24
-39.96
-414.17
-80.77
-196.98
Working Capital
-11
-9
-29
-14
-14
-7
-7
-3
-1
-1
-1
LT Debt
- -
- -
- -
- -
- -
- -
- -
2
1
- -
1
Total Equity
-11
-9
-8
-13
-14
-7
-6
-5
- -
-1
-2
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
-16.98
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -

Capital Structure

FRC

•

in mil. unless spec.
Dec'21
Mar'22
Jun'22
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
1
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
62
62
62
Market Capitalization
7
5
5

Working Capital

FRC

•

in mil. unless spec.
Dec'21
Mar'22
Jun'22
Total Current Assets
- -
- -
- -
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
1
2
2
Payables & Accruals
- -
- -
1
ST Debt
- -
- -
- -
Deferred Revenue
1
1
1

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
85.64%
602.21%
Free Cash Flow
- -
5.49%
-78.14%
Net Income, GAAP
- -
56.97%
-34.21%
Sales/Revenue/Turnover
- -
94.39%
237.35%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2020
- -
- -
- -
- -
- -
2021
- -
1
- -
- -
1
2022
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2020
-0.01
-0.01
-0.01
- -
-0.03
2021
- -
-0.01
- -
- -
-0.02
2022
- -
-0.01
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2020
- -
- -
- -
- -
- -
2021
- -
- -
- -
- -
- -
2022
- -
- -
- -
- -
- -

Company Description

APIChat
CEO
Ding Hua Wang
Full Time Employees
6
Sector
Consumer Defensive
Industry
Packaged Foods
Address
100 North Barranca Street West Covina CA United States of America 91791
IPO Date
Sep 10, 2015
CIK
0001517498
Website
merionus.com
Similar Companies
Asian Alliance International Public Company Limited (AAI.BK)
Haitai Confectionery&Foods Co.,ltd. (101530.KS)
La Doria S.p.A. (0F2Q.L)
Zhejiang Yiming Food Co., Ltd. (605179.SS)
The Kraft Heinz Company (KHC.SW)
PT Prasidha Aneka Niaga Tbk (PSDN.JK)
Business
Merion, Inc. is a biotechnology company founded in 2007 and headquartered in West Covina, California. The company specializes in the development, manufacturing, and distribution of health and nutritional supplements and personal care products, primarily operating in the United States and China. Its product portfolio includes custom-formulated capsules, powders, and tablets made from 100% plant extracts with small molecular nutrition and cellular carrier technology. Merion also imports and distributes medical devices and herbal ingredients and offers e-commerce services alongside healthcare information through its E-Hospital platform. The company is engaged in developing advanced biopharmaceuticals and blockchain anti-counterfeiting technology. Recent major developments at Merion include the continued launch of advanced small molecule and cell carrier nutrient products tailored to evolving market demands, with a strong focus on online and offline sales expansion through its e-commerce platforms, leading to consistent annual sales growth. Merion maintains a premier global biotechnology research and development team to support product innovation. The company was formerly known as E-WORLD USA HOLDING, INC. Its key products include nutritional supplements with potent ingredients such as nicotinamide mononucleotide (NMN) for metabolism enhancement and anti-aging benefits, demonstrating a commitment to innovation in health and wellness biotechnology. Merion operates within the biotechnology and personal care product sectors targeting consumers seeking health supplements, wellness products, and related medical devices, with a focus on both American and Chinese markets. The company continues expanding its product offerings and market presence through technological advancements and strategic e-commerce channel development, positioning itself as a leader in plant-derived nutritional supplement technology and biopharmaceutical development. It trades under the ticker EWLU on the OTC market.